Impaired skeletal growth in mice with haploinsufficiency of IGF-I: Genetic evidence that differences in IGF-I expression could contribute to peak bone mineral density differences

Journal of Endocrinology

Volumn 185, Issue 3, 2005, Pages 415-420

  Mohan, Subburaman ^a,b   Baylink, D J ^a,b  

^a Jerry L Pettis Memorial VA Medical Center   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C;

ADULTHOOD; ALLELE; ANIMAL EXPERIMENT; ARTICLE; BONE DENSITY; BONE GROWTH; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAPHYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMUR; GENE EXPRESSION; GENETIC VARIABILITY; HETEROZYGOSITY; KNOCKOUT GENE; MOUSE; MOUSE STRAIN; NONHUMAN; PERIOSTEUM; PREPUBERTY; PRIORITY JOURNAL; PUBERTY; STATISTICAL ANALYSIS; VOLUMETRY;

ANIMALS; BONE DENSITY; BONE DEVELOPMENT; DENSITOMETRY, X-RAY; FEMUR; GENE EXPRESSION; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, KNOCKOUT; RADIOIMMUNOASSAY; SEXUAL MATURATION;

EID: 21244447403     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06141     Document Type: Article

References (29)

1. Baldock PA & Eisman JA 2004 Genetic determinants of bone mass. Current Opinion in Rheumatology 16 450-456.
2. Bikle D, Majumdar S, Laib A, Powell-Braxton L, Rosen C, Beamer W, Nauman E, Leary C & Halloran B 2001 The skeletal structure of insulin-like growth factor I-deficient mice. Journal of Bone and Mineral Research 16 2320-2329.
3. Bikle DD, Sakata T, Leary C, Elalieh H, Ginzinger D, Rosen CJ, Beamer W, Majumdar S & Halloran BP 2002 Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone. Journal of Bone and Mineral Research 17 1570-1578.
4. Bouxsein ML, Rosen CJ, Turner CH, Ackert CL, Shultz KL, Donahue LR, Churchill G, Adamo ML, Powell DR, Turner RT et al. 2002 Generation of a new congenic mouse strain to test the relationships among serum insulin-like growth factor I, bone mineral density, and skeletal morphology in vivo. Journal of Bone and Mineral Research 17 570-579.
5. Eckstein F, Weusten A, Schmidt C, Wehr U, Wanke R, Rambeck W, Wolf E & Mohan S 2004 Longitudinal in vivo effects of growth hormone overexpression on bone in transgenic mice. Journal of Bone and Mineral Research 19 802-810.
6. Harrela M, Koistinen H, Kaprio J, Lehtovirta M, Tuomilehto J, Eriksson J, Toivanen L, Koskenvuo M, Leinonen P, Koistinen R et al. 1996 Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. Journal of Clinical Investigation 98 2612-2615.
7. Hoshi K, Ogata N, Shimoaka T, Terauchi Y, Kadowaki T, Kenmotsu S, Chung UI, Ozawa H, Nakamura K & Kawaguchi H 2004 Deficiency of insulin receptor substrate-1 impairs skeletal growth through early closure of epiphyseal cartilage. Journal of Bone and Mineral Research 19 214-223.
8. Johnston LB, Dahlgren J, Leger J, Gelander L, Savage MO, Czernichow P, Wikland KA & Clark AJ 2003 Association between insulin-like growth factor I (IGF-I) polymorphisms, circulating IGF-I, and pre- and postnatal growth in two European small for gestational age populations. Journal of Clinical Endocrinology and Metabolism 88 4805-4810.
9. Kasukawa Y, Baylink DJ, Wergedal JE, Amaar Y, Srivastava AK, Guo R & Mohan S 2003 Lack of insulin-like growth factor I exaggerates the effect of calcium deficiency on bone accretion in mice. Endocrinology 144 4682-4689.
10. Kasukawa Y, Miyakoshi N & Mohan S 2004 The anabolic effects of GH/IGF system on bone. Current Pharmaceutical Design 10 2577-2592.
11. Libanati C, Baylink DJ, Lois-Wenzel E, Srinvasan N & Mohan S 1999 Studies on the potential mediators of skeletal changes occurring during puberty in girls. Journal of Clinical Endocrinology and Metabolism 84 2807-2814.
12. Miyakoshi N, Kasukawa Y, Linkhart TA, Baylink DJ & Mohan S 2001 Evidence that anabolic effects of PTH on bone require IGF-I in growing mice. Endocrinology 142 4349-4356.
13. Mohan S & Baylink DJ 1995 Development of a simple valid method for the complete removal of insulin-like growth factor (IGF)-binding proteins from IGFs in human serum and other biological fluids: comparison with acid-ethanol treatment and C18 Sep-Pak separation. Journal of Clinical Endocrinology and Metabolism 80 637-647.
14. Mohan S & Baylink DJ 1999 Role of growth hormone/insulin-like growth factor axis. In The Aging Skeleton, pp 209-219. Eds GJ Rosen & JP Bilezikian. San Diego: Academic Press.
15. Mohan S, Richman C, Guo R, Amaar Y, Donahue LR, Wergedal J & Baylink DJ 2003 Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms. Endocrinology 144 929-936.
16. Moreira-Andres MN, Papapietro K, Canizo FJ, Rejas J, Larrodera L & Hawkins FG 1995 Correlations between bone mineral density, insulin-like growth factor I and auxological variables. European Journal of Endocrinology 132 573-579.
17. Nielsen EM, Hansen L, Lajer M, Andersen KL, Echwald SM, Urhammer SA, Hansen T & Pedersen O 2004 A common polymorphism in the promoter of the IGF-I gene associates with increased fasting serum triglyceride levels in glucose-tolerant subjects. Clinical Biochemistry 37 660-665.
18. Rajaram S, Baylink DJ & Mohan S 1997 Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocrine Reviews 18 801-831.
19. Recker RR & Deng HW 2002 Role of genetics in osteoporosis. Endocrine 17 55-66.
20. Richman C, Kutilek S, Miyakoshi N, Srivastava AK, Beamer WG, Donahue LR, Rosen CJ, Wergedal JE, Baylink DJ & Mohan S 2001 Postnatal and pubertal skeletal changes contribute predominantly to the differences in peak bone density between C3H/HeJ and C57BL/6J mice. Journal of Bone and Mineral Research 16 386-397.
21. Rietveld I, Janssen JA, Hofman A, Pols HA, van Duijn CM & Lamberts SW 2003 A polymorphism in the IGF-I gene influences the age-related decline in circulating total IGF-I levels. European Journal of Endocrinology 148 171-175.
22. Rietveld I, Janssen JA, van Rossum EF, Houwing-Duistermaat JJ, Rivadeneira F, Hofman A, Pols HA, van Duijn CM & Lamberts SW 2004 A polymorphic CA repeat in the IGF-I gene is associated with gender-specific differences in body height, but has no effect on the secular trend in body height. Clinical Endocrinology 61 195-203.
23. Rosen CJ, Kurland ES, Vereault D, Adler RA, Rackoff PJ, Craig WY, Witte S, Rogers J & Bilezikian JP 1998 Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density. Journal of Clinical Endocrinology and Metabolism 83 2286-2290
24. Saban J, Schneider GB, Bolt D & King D 1996 Erythroid-specific expression of human growth hormone affects bone morphology in transgenic mice. Bone 18 47-52.
25. Thorsen K, Nordstrom P, Lorentzon R & Dahlen GH 1999 The relation between bone mineral density, insulin-like growth factor I, lipoprotein (a), body composition, and muscle strength in adolescent males. Journal of Clinical Endocrinology and Metabolism 84 3025-3029.
26. Woods KA, Camacho-Hubner C, Barter D, Clark AJ & Savage MO 1997 Insulin-like growth factor I gene deletion causing intrauterine growth retardation and severe short stature. Acta Paediatrica 423 (Suppl) 39-45.
27. Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL, Wu Y, Liu JL, Ooi GT, Setser J, Frystyk J, Boisclair YR et al. 2002 Circulating levels of IGF-1 directly regulate bone growth and density. Journal of Clinical Investigation 110 771-781.
28. Zhang M, Xuan S, Bouxsein ML, von Stechow D, Akeno N, Faugere MC, Malluche H, Zhao G, Rosen CJ, Efstratiadis A et al. 2002 Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. Journal of Biological Chemistry 277 44005-44012.
29. Zhao G, Monier-Faugere MC, Langub MC, Geng Z, Nakayama T, Pike JW, Chernausek SD, Rosen CJ, Donahue LR, Malluche HH et al. 2000 Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinology 141 2674-2682.